1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 3,310 | 3,320 | 30.12.25 | |
| 0,000 | 0,000 | 30.12.25 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| BIOTALYS Aktie jetzt für 0€ handeln | |||||
| 02.12.25 | Biotalys Secures EPA Approval For EVOCA, First Protein-Based Biofungicide | 1 | RTTNews | ||
| 02.12.25 | Biotalys NV: Biotalys Receives Regulatory Approval by U.S. EPA for EVOCA | 472 | GlobeNewswire (Europe) | U.S. Registration Marks a Significant Milestone as the First Protein-Based Biofungicide of its Kind to be Approved by the EPAGhent, BELGIUM, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Press release - inside... ► Artikel lesen | |
| 03.11.25 | XFRA 86C: WIEDERAUFNAHME/RESUMPTION | 264 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 31.10.25 | Biotalys shares jump as EPA proposes registration of first biofungicide | 3 | Investing.com | ||
| 31.10.25 | Biotalys NV: EPA Issues Proposed Registration Decision for Biotalys' EVOCA Biofungicide | 458 | GlobeNewswire (Europe) | U.S. Environmental Protection Agency Initiates Public Participation ProcedureGhent, Belgium, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Press release - inside information
EPA Issues Proposed Registration... ► Artikel lesen | |
| 30.10.25 | XFRA 86C: AUSSETZUNG/SUSPENSION | 280 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILBIOTALYS NV 86C... ► Artikel lesen | |
| 20.10.25 | Biotalys NV: Regulated information | 368 | GlobeNewswire (Europe) | Information on the total number of voting rights and sharesGhent, Belgium, Oct. 20, 2025(hereafter the "Company" or "Biotalys") today announces, in accordance with article 15 of the Belgian Act of 2... ► Artikel lesen | |
| 18.09.25 | Biotalys NV H1 Loss Climbs | 2 | RTTNews | ||
| 18.09.25 | Biotalys NV: Biotalys Reports Half-Year 2025 Financial Results and Business Highlights | 510 | GlobeNewswire (Europe) | Press release - regulated informationGhent, Belgium, Sept. 18, 2025 (GLOBE NEWSWIRE) --
Substantial progress in both the U.S. and Europe in the regulatory review of Biotalys' first candidate... ► Artikel lesen | |
| 29.08.25 | Biotalys NV: Biotalys Provides Regulatory Review Update for EVOCA in the U.S. | 477 | GlobeNewswire (Europe) | Inside informationGhent, BELGIUM, Aug. 29, 2025) today provides an update on the regulatory approval procedure in the United States of its first protein-based biocontrol product, EVOCA*.
Biotalys... ► Artikel lesen | |
| 30.07.25 | Biotalys NV: Information on the total number of voting rights and shares | 466 | GlobeNewswire (Europe) | Press Release - Regulated InformationGhent, BELGIUM, July 30, 2025(hereafter the "Company" or "Biotalys"), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for... ► Artikel lesen | |
| 16.06.25 | Biotalys NV: Publication of transparency notification | 552 | GlobeNewswire (Europe) | Article 14(1) of the Law of 2 May 2007 on the disclosure of large shareholders in issuers whose shares are admitted to trading on a regulated marketGhent, BELGIUM, June 16, 2025 (GLOBE NEWSWIRE) --... ► Artikel lesen | |
| 11.06.25 | Biotalys NV: Biotalys Reports Progress in the Regulatory Review of EVOCA in both US and EU | 620 | GlobeNewswire (Europe) | US EPA projects taking a regulatory decision by end of September 2025; Dutch authorities finalise first phase of regulatory dossier for EVOCA in Europe Ghent, BELGIUM, June 11, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| 26.05.25 | Biotalys NV: Biotalys Appoints Luc Van fraeyenhoven as Chief Financial Officer | 519 | GlobeNewswire (Europe) | Seasoned Financial Executive Will Lead Finance Operations as Biotalys Pushes Product Pipeline Toward Commercialization Ghent, May 26, 2025 (GLOBE NEWSWIRE) -- Press release
Ghent, BELGIUM - 26... ► Artikel lesen | |
| 20.05.25 | Biotalys NV: Biotalys and AgroFresh Partner to Protect Fresh Produce | 448 | GlobeNewswire (Europe) | Global leaders in sustainable agricultural innovation to develop biological solutions to reduce food wasteGhent, BELGIUM, and Philadelphia, USA, May 20, 2025 (GLOBE NEWSWIRE) -- Press release
Ghent... ► Artikel lesen | |
| 22.04.25 | Biotalys NV: Results of the Ordinary Shareholders' Meeting | 353 | GlobeNewswire (Europe) | Regulated InformationGhent, Belgium, April 22, 2025)of the Company. The minutes will be made available in due course.
For further information, please contact:Toon Musschoot, Head of Investor Relations... ► Artikel lesen | |
| 25.03.25 | Biotalys NV: Biotalys to Appoint Toni Bucci to its Board of Directors | 901 | GlobeNewswire (Europe) | Seasoned Agriculture and Biotech Executive With a Passion to Feed the World SustainablyGhent, BELGIUM, March 25, 2025 (GLOBE NEWSWIRE) -- Press release
Biotalys), an Agricultural Technology (AgTech)... ► Artikel lesen | |
| 21.03.25 | Biotalys NV: Invitation to the ordinary general shareholders meeting | 512 | GlobeNewswire (Europe) | Ghent, BELGIUM, March 21, 2025 (GLOBE NEWSWIRE) -- Press release - regulated information
Biotalys(the "Company" or "Biotalys"), an Agricultural Technology (AgTech) company developing protein-based... ► Artikel lesen | |
| 19.03.25 | Biotalys NV: Biotalys Reports Full-Year 2024 Financial Results and Business Highlights | 854 | GlobeNewswire (Europe) | Ghent, BELGIUM, March 19, 2025 (GLOBE NEWSWIRE) -- Press release - regulated information
Continued to work closely with European and U.S. regulators on the regulatory review of its first candidate... ► Artikel lesen | |
| 11.03.25 | Biotalys NV: Biotalys Achieves Strong Results in Field Trials with Second Biofungicide | 423 | GlobeNewswire (Europe) | BioFun-6 Candidate Shows Excellent Efficacy with Increased Potency Ghent, March 11, 2025 (GLOBE NEWSWIRE) -- Press Release
Biotalys ), an Agricultural Technology (AgTech) company developing... ► Artikel lesen |
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| K+S | 12,420 | +0,16 % | EQS-PVR: K+S Aktiengesellschaft: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: K+S Aktiengesellschaft
K+S Aktiengesellschaft: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
30.12.2025 / 18:05... ► Artikel lesen | |
| CARBIOS | 11,300 | +0,36 % | AKTIONÄR-Hot-Stock Carbios: Besser spät als nie | Der französische Spezialist für das enzymatische Recycling von Plastik hat dem Kapitalmarkt vor dem Weihnachtsfest ein Update zum Zeitplan für den Bau der geplanten Anlage im heimischen Longlaville... ► Artikel lesen | |
| UMICORE | 18,080 | +0,06 % | Megatrend eWaste: Diese Aktien sollten Anleger 2026 im Blick behalten -Iondrive, Salzgitter und Umicore im Vergleich | ||
| YARA INTERNATIONAL | 34,980 | +0,03 % | Yara International ASA: Air Products and Yara in Advanced Negotiations to Partner on Low-emission Ammonia Projects | Plans connect Air Products' low-emission ammonia projects in the U.S. and Saudi Arabia with Yara's world-scale ammonia network.Final Investment Decisions by both companies for the U.S. project... ► Artikel lesen | |
| DUPONT DE NEMOURS | 34,630 | -0,33 % | Dividendenbekanntmachungen (28.11.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGNC INVESTMENT CORP US00123Q1040 0,12 USD 0,1034 EUR AGREE REALTY CORPORATION US0084921008 0,262 USD 0,2259 EUR ALLIED PROPERTIES... ► Artikel lesen | |
| THE MOSAIC | 20,640 | +0,73 % | Mosaic exits New Mexico potash with $30 mn Carlsbad sale | ||
| AKZO NOBEL | 59,38 | -0,13 % | GOLDMAN SACHS stuft AKZO NOBEL NV auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Akzo Nobel von 63 auf 72 Euro angehoben und die Einstufung auf "Buy" belassen. Analystin Georgina Fraser passte... ► Artikel lesen | |
| AVANTIUM | 6,849 | -0,09 % | Avantium N.V.: Avantium, LVMH and Tereos form strategic alliance to scale releaf production across Europe | AMSTERDAM, 23 September 2025, 07:00 hrs CEST - Avantium N.V., a leader in renewable and circular polymer materials, announces that it has signed Memoranda of Understanding with Tereos, a global leader... ► Artikel lesen | |
| GRAPHENE MANUFACTURING GROUP | 1,134 | +3,47 % | Graphene Manufacturing Group Ltd.: USA EPA Approval Conditions Accepted for Graphene Coating THERMAL-XR(R) | Brisbane, Australia--(Newsfile Corp. - December 22, 2025) - Graphene Manufacturing Group Ltd. (TSXV: GMG) ("GMG" or the "Company") is pleased to provide a business update on the commercialisation... ► Artikel lesen | |
| HB FULLER | 52,00 | +0,97 % | Dividendenbekanntmachungen (16.10.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) APARTMENT INVESTMENT AND MANAGEMENT COMP ... US03748R7474 2,23 USD 1,9149 EUR AZZ INC US0024741045 0,2 USD 0,1717 EUR CHINA CONCH... ► Artikel lesen | |
| AVANTOR | 9,800 | +0,51 % | Faruqi & Faruqi LLP: DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor | Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered in Avantor to Contact Him Directly to Discuss Their OptionsIf you purchased or acquired securities... ► Artikel lesen | |
| ICL GROUP | 5,705 | 0,00 % | ICL expanding in flavor, shelf life through acquisition: Bartek Ingredients supplies malic and fumaric acid | ||
| ADC THERAPEUTICS | 3,555 | 0,00 % | ADC Therapeutics SA: ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combination with Bispecific Antibody Supporting Potential Best-in-Class Regimen in Patients with Relapsed/Refractory Diffuse Large ... | ZYNLONTA® in combination with glofitamab (COLUMVI®) demonstrated an 89.8% ORR and 77.6% CR across the 49 efficacy-evaluable patients with a minimum of 6 months of... ► Artikel lesen | |
| CVR PARTNERS | 102,56 | +4,26 % | CVR Partners, LP: CVR Partners Reports Second Quarter 2025 Results | Second quarter net income of $39 million, or $3.67 per common unit; EBITDA of $67 millionAnnounced cash distribution of $3.89 per common unit SUGAR LAND, Texas, July 30, 2025 (GLOBE NEWSWIRE) --... ► Artikel lesen | |
| WESTLAKE CHEMICAL PARTNERS | 19,025 | 0,00 % | Westlake Chemical Partners announce renewal of ethylene sales agreement |
BIOTALYS NV gehört der Branche Chemie an. Die relative Kursveränderung beträgt aktuell +0,60 % bei einem Aktienkurs von 3,340 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIOTALYS NV finden Sie auf Wallstreet Online.